A PSICOEDUCAÇÃO NA PROMOÇÃO DO INSIGHT E NA ADESÃO AO REGIME TERAPÊUTICO EM PESSOAS COM DOENÇA MENTAL GRAVE: UMA SCOPING REVIEW

Catarina Louro, Mónica Lopo Tomaz, Liliana Barroso de Sousa, Celso Silva

Resumo


Introdução: A fraca adesão ao tratamento e a ausência de insight são fatores significativos que contribuem para um pior prognóstico em pessoas com doença mental grave. É essencial conhecermos os contributos das intervenções psicoeducativas na promoção do insight e na adesão ao regime terapêutico destas pessoas. Objetivo: Mapear os efeitos da psicoeducação na promoção do insight e adesão ao regime terapêutico em pessoas com doença mental grave. Métodos: Realização de uma scoping review, com base nas recomendações do Joanna Briggs Institute. Realizou-se uma pesquisa na plataforma EBSCO e nas bases de dados CINAHL Ultimate, Medline Ultimate, Psychology and Behavioral Sciences Collection, Mediclatina, Medline with Full Text e CINAHL Plus with Full Text em março de 2025, procurando-se estudos no período temporal de cinco anos (2020 a 2025). Resultados: Foram identificados 185 artigos e após os critérios de inclusão previamente definidos, foram selecionados quatro estudos para análise final. As intervenções realizadas nesses estudos foram a aplicação de programas de psicoeducação em exclusivo e em complemento com outras intervenções. Através da recolha de dados antes e após a intervenção com recurso a escalas, verificou-se um aumento do insight e da adesão ao regime terapêutico, para além da redução do estigma e da melhoria da qualidade de vida. Conclusão: Os artigos evidenciam o efeito benéfico da psicoeducação em pessoas com doença mental grave. Palavras-Chave: Psicoeducação; Doença mental grave; Adesão terapêutica; Insight

 


Texto Completo:

PDF PDF (English)

Referências


James SL, Abate D, Abate KH, Abay SM, Abbafati C, Abbasi N, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov;392(10159):1789–858.

Fuller Torrey E. Epidemiological comparison of schizophrenia and bipolar disorder. Schizophr Res. 1999 Sep;39(2):101–6.

Ratanatharathorn A, Chibnik LB, Koenen KC, Weisskopf MG, Roberts AL. Association of maternal polygenic risk scores for mental illness with perinatal risk factors for offspring mental illness. Sci Adv. 2022 Dec 16;8(50).

Pradhan BK, Chakrabarti S, Nehra R, Mankotia A. Cognitive functions in bipolar affective disorder and schizophrenia: Comparison. Psychiatry Clin Neurosci. 2008 Oct 29;62(5):515–25.

Sciortino D, Pigoni A, Delvecchio G, Maggioni E, Schiena G, Brambilla P. Role of rTMS in the treatment of cognitive impairments in Bipolar Disorder and Schizophrenia: a review of Randomized Controlled Trials. J Affect Disord. 2021 Feb;280:148–55.

Saarni SI, Viertiö S, Perälä J, Koskinen S, Lönnqvist J, Suvisaari J. Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br J Psychiatry. 2010 Nov 2;197(5):386–94.

Degnan A, Berry K, Humphrey C, Bucci S. The relationship between stigma and subjective quality of life in psychosis: A systematic review and meta-analysis. Clin Psychol Rev. 2021 Apr;85:102003.

Laursen TM. Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res. 2011 Sep;131(1–3):101–4.

Chan JKN, Correll CU, Wong CSM, Chu RST, Fung VSC, Wong GHS, et al. Life expectancy and years of potential life lost in people with mental disorders: a systematic review and meta-analysis. eClinicalMedicine. 2023 Nov;65:102294.

Šimunović Filipčić I, Filipčić I. Schizophrenia and physical comorbidity. Psychiatr Danub [Internet]. 2018 [cited 2025 Nov 22];30(suppl. 4):152–7. Available from: https://hrcak.srce.hr/clanak/382172

Cho JM, Lee K. Effects of motivation interviewing using a group art therapy program on negative symptoms of schizophrenia. Arch Psychiatr Nurs. 2018 Dec;32(6):878–84.

American Psychiatric Association [APA]. Manual de Diagnóstico e Estatística das Perturbações Mentais. 5.a. Climepsi; 2022.

Hasan AA, Jaber AA. The effect of a family intervention on primary caregivers psychological outcomes: Findings from the integrative literature review. Perspect Psychiatr Care. 2019 Apr 3;55(2):277–90.

National Alliance on Mental Illness [NAMI]. Bipolar disorder [Internet]. 2017 [cited 2025 Nov 22]. Available from: https://www.nami.org/About-Mental-Illness/Mental-Health-Conditions/Bipolar-Disorder/

National Institute of Mental Health [NIMH]. Bipolar disorder: Transforming the understanding and treatment of mental illnesses [Internet]. 2024 [cited 2025 Nov 22]. Available from: https://www.nimh.nih.gov/health/topics/bipolar-disorder

Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol. 2018 Sep 26;8(9):251–69.

World Health Organization. Mental disorders: Key facts [Internet]. 2022 [cited 2025 Nov 22]. Available from: https://www.who.int/news-room/fact-sheets/detail/mental-disorders

Dobber J, Latour C, de Haan L, Scholte op Reimer W, Peters R, Barkhof E, et al. Medication adherence in patients with schizophrenia: a qualitative study of the patient process in motivational interviewing. BMC Psychiatry. 2018 Dec 18;18(1):135.

Jawad I, Watson S, Haddad PM, Talbot PS, McAllister-Williams RH. Medication nonadherence in bipolar disorder: a narrative review. Ther Adv Psychopharmacol. 2018 Dec 16;8(12):349–63.

Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty J. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017 Mar;Volume 11:449–68.

Solmi M, Cortese S, Vita G, De Prisco M, Radua J, Dragioti E, et al. An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders. Mol Psychiatry. 2023 Sep 13;28(9):3671–87.

Van Camp LSC, Sabbe BGC, Oldenburg JFE. Cognitive insight: A systematic review. Clin Psychol Rev. 2017 Jul;55:12–24.

Crișan CA. Lack of Insight in Bipolar Disorder: The Impact on Treatment Adherence, Adverse Clinical Outcomes and Quality of Life. In: Psychotic Disorders - An Update. InTech; 2018.

Oneib B, Mansour A, Bouazzaoui MA. The effect of psychoeducation on clinical symptoms, adherence, insight and autonomy in patients with schizophrenia. Discov Ment Heal. 2025 Feb 28;5(1):26.

Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024.

Peters MD, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Scoping reviews. In: JBI Manual for Evidence Synthesis. JBI; 2024.

Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127–33.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29;n71.

Harmanci P, Budak FK. The Effect of Psychoeducation Based on Motivational Interview Techniques on Medication Adherence, Hope, and Psychological Well-Being in Schizophrenia Patients. Clin Nurs Res. 2022 Feb 1;31(2):202–16.

Alhadidi M, Hadid LAR Al, Danaee M, Abdullah KL, Yoong TL. Effects of Psychoeducation on People With Schizophrenia in Long-Term Care: An Intervention Study. J Psychosoc Nurs Ment Health Serv. 2023 Feb;61(2):9–18.

Balikai SI, Rentala S, Mudakavi IB, Nayak RB. Impact of nurse‐led medication adherence therapy on bipolar affective disorder: A randomized controlled trial. Perspect Psychiatr Care. 2022 Oct 13;58(4):2676–86.

El-Amrosy S, Shereda H. The Effect of Mindfulness-Based Psycho-Educational Program on Insight and Socio Occupational Functioning of Schizophrenic Patients. Int J Nurs Educ. 2020;12(4):215–26.

Ertem M, Duman ZÇ. Motivational Interviewing in a Patient With Schizophrenia to Achieve Treatment Collaboration: A Case Study. Arch Psychiatr Nurs. 2016 Apr;30(2):150–4.

Dufort A, Zipursky RB. Understanding and Managing Treatment Adherence in Schizophrenia. Clin Schizophr Relat Psychoses. 2019 Jan 3;

Ghazi G, Maximos M, Imam S. Impact of a Psycho-Education Intervention on Insight of Hospitalized Schizophrenic Patients. J High Inst Public Heal. 2007 Apr 1;37(2):279–304.

von Maffei C, Görges F, Kissling W, Schreiber W, Rummel-Kluge C. Using films as a psychoeducation tool for patients with schizophrenia: a pilot study using a quasi-experimental pre-post design. BMC Psychiatry. 2015 Dec 30;15(1):93.

Zhao S, Sampson S, Xia J, Jayaram MB. Psychoeducation (brief) for people with serious mental illness. Cochrane Database Syst Rev. 2015 Apr 9;2015(4).

Ching Lan Lin E, Berk M, Chen Hsu P, Band Lu R. A nurse-led psychoeducational program BalancingMySwing improves medication adherence among Taiwanese Han-Chinese with bipolar II disorder. Neuropsychiatry (London). 2018;07(04).

Chien WT, Thompson DR. Effects of a mindfulness-based psychoeducation programme for Chinese patients with schizophrenia: 2-year follow-up. Br J Psychiatry. 2014 Jul 2;205(1):52–9.

Chien WT, Lee IYM. The Mindfulness-Based Psychoeducation Program for Chinese Patients With Schizophrenia. Psychiatr Serv. 2013 Apr;64(4):376–9.

Choe K, Sung BJ, Kang Y, Yoo SY. Impact of Psychoeducation on Knowledge of and Attitude Toward Medications in Clients With Schizophrenia and Schizoaffective Disorders. Perspect Psychiatr Care. 2016 Apr;52(2):113–9.

Alizioti A, Lyrakos G. Measuring the effectiveness of psychoeducation on adherence, depression, anxiety and stress among patients with diagnosis of schizophrenia. a control trial. Curr Psychol. 2021 Aug 5;40(8):3639–50.

Vilar T, Nogueira MJ, Valentim O, Seabra P. A psicoeducação na adesão terapêutica em utentes com esquizofrenia: Uma scoping review. Rev Port Enferm Saúde Ment. 2020 Oct;(7).




DOI: http://dx.doi.org/10.60468/r.riase.2025.11(03).816.48-58

Apontamentos

  • Não há apontamentos.